Overview

Venetoclax and Decitabine in R/R T-ALL

Status:
NOT_YET_RECRUITING

Trial end date:
2028-08-31

Target enrollment:

Participant gender:

Summary

The goal of this phase 2 clinical trial is to test the efficacy of decitabine and venetoclax combination chemotherapy in relapsed or refractory adult T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. This study use a modified regimen of decitabine and venetoclax.

Phase:

PHASE2

Details

Lead Sponsor:

Seoul National University Hospital

Collaborator:

Korean Society of Hematology

Treatments:

Decitabine
venetoclax